A formulated cannabis product includes a cannabinoid mix and carrier processed by nano-emulsification. The cannabinoid mix in one embodiment includes between 0.1-0.3% Cannabinol (CBN). This cannabinoid mix is processed into a product yielding between 10-100 μg of CBN in each dose. The cannabinoid mix can include primary cannabinoids extracted from cannabis sativa (hemp or marijuana) plant material including tetrahydrocannabinol, cannabidiol, and combinations thereof. The cannabinoid mix includes isolated terpenes selected from the group consisting of, D-Limonene, α-Pinene, Myrcene, Linalool, and combinations thereof. These terpenes have a purity of 99% or greater. The isolated terpenes are from cannabis sativa plant material comprising between 0.2-10% of the cannabinoid mix. In another embodiment, at least a portion of these terpenes are derived from plants other than cannabis sativa. In a further embodiment, the formulated product includes a terpene rich essential oil derived from peppermint
